Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schmitz

Showing results (181-190 of 222) with videos related to

Pageof 23
Sort By:
European Journal of Haematology|May 7, 2004
Acquired pure megakaryocytic aplasia: a separate haematological disease entity or a syndrome with multiple causes?P Felderbauer, P R Ritter, D Mattern, et al.
Der Nervenarzt|September 1, 1994
[Frontal and temporal onset of brain atrophy. Clinical and instrumental findings]H Förstl, F Hentschel, C Besthorn, et al.
Journal of Health Care for the Poor and Underserved|January 21, 2022
Promoting Health Careers Among Rural K-16 Students: A Mixed-Method Study to Describe Pathway ProgramsAndrew D Jopson, Samantha W Pollack, David F Schmitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?J Bernhard, B Thürlimann, S F Schmitz, et al.
Human Molecular Genetics|July 21, 1998
Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1A Klose, M R Ahmadian, M Schuelke, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK)J Bernhard, M Castiglione-Gertsch, S F Schmitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK)T Cerny, S Leyvraz, T von Briel, et al.
The Journal of Clinical Investigation|February 2, 1999
The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weightA S Kopin, W F Mathes, E W McBride, et al.
Journal of Dairy Science|September 25, 2019
Genome-wide mapping of the dominance effects based on breed ancestry for semen traits in admixed Swiss Fleckvieh bullsN Khayatzadeh, G Mészáros, Y T Utsunomiya, et al.
Journal of Dairy Science|March 13, 2017
A reaction norm sire model to study the effect of metabolic challenge in early lactation on the functional longevity of dairy cowsN-T Ha, A R Sharifi, J Heise, et al.
Pageof 23

Showing results (181-190 of 222) with videos related to

Sort By:
Pageof 23
European Journal of Haematology|May 7, 2004
Acquired pure megakaryocytic aplasia: a separate haematological disease entity or a syndrome with multiple causes?P Felderbauer, P R Ritter, D Mattern, et al.
Der Nervenarzt|September 1, 1994
[Frontal and temporal onset of brain atrophy. Clinical and instrumental findings]H Förstl, F Hentschel, C Besthorn, et al.
Journal of Health Care for the Poor and Underserved|January 21, 2022
Promoting Health Careers Among Rural K-16 Students: A Mixed-Method Study to Describe Pathway ProgramsAndrew D Jopson, Samantha W Pollack, David F Schmitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?J Bernhard, B Thürlimann, S F Schmitz, et al.
Human Molecular Genetics|July 21, 1998
Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1A Klose, M R Ahmadian, M Schuelke, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK)J Bernhard, M Castiglione-Gertsch, S F Schmitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK)T Cerny, S Leyvraz, T von Briel, et al.
The Journal of Clinical Investigation|February 2, 1999
The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weightA S Kopin, W F Mathes, E W McBride, et al.
Journal of Dairy Science|September 25, 2019
Genome-wide mapping of the dominance effects based on breed ancestry for semen traits in admixed Swiss Fleckvieh bullsN Khayatzadeh, G Mészáros, Y T Utsunomiya, et al.
Journal of Dairy Science|March 13, 2017
A reaction norm sire model to study the effect of metabolic challenge in early lactation on the functional longevity of dairy cowsN-T Ha, A R Sharifi, J Heise, et al.
Pageof 23